Clinical Trials
6 trialsNCT04345718 2025-12-09
EXHITENTRE
Hennepin Healthcare Research Institute
Phase 2/3 Completed
NCT00003816 2021-08-13
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Roswell Park Cancer Institute
Phase 2/3 Completed
NCT02612415 2016-12-16
FIRST-ABC
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 2/3 Completed
NCT00147121 2016-09-22
Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)
Japan Clinical Oncology Group
Phase 2/3 Completed
NCT02072330 2014-02-26
Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.
Takeda
Phase 2/3 Completed
NCT00045877 2006-02-06
Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
Chiron Corporation
Phase 2/3 Completed